No Data
No Data
Merit Medical Systems Insiders Sold US$556k Of Shares Suggesting Hesitancy
CCORF Maintains Merit Medical Systems(MMSI.US) With Buy Rating, Maintains Target Price $127
Needham Maintains Merit Medical Systems(MMSI.US) With Buy Rating, Maintains Target Price $109
Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX), Vivani Medical (VANI) and Merit Medical Systems (MMSI)
Express News | Merit Medical Systems Inc - to Begin Commercialization of Wrapsody in USA in 2025
Merit Medical Announces FDA Approval of the WRAPSODY Cell-Impermeable Endoprosthesis